Development of an Escape-resistant SARS CoV-2 Neutralizing Synthetic Nanobody
Dmitri Dormeshkin, Michail A. Shapira, Simon Dubovik, Anton Kavaleuski, Mikalai Katsin, Alexandr A. Migas, Alexander Meleshko, Sergei Semyonov
The paper develops synthetic nanobodies that neutralize SARS-CoV-2 variants with high affinity and low susceptibility to mutations.
Frontiers in Immunology · Sep 16, 2022Peer-reviewedSynthetic Biology